NeurologyLive Friday 5 — October 29, 2021

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Induction vs Escalation for MS: Should Patients Be Started on High-Efficacy DMT?

In the presidential lecture series at CMSC 2021, Ellen M. Mowry, MD, called into question whether or not the induction treatment approach in multiple sclerosis does in fact present a higher chance of preventing long-term disability.

2: Accessible Stroke Care for Diverse Populations: The Montefiore Approach

Years of built-up trust in the community has enabled Montefiore’s Stern Stroke Center physicians to understand more about how stroke affects multicultural communities and to break down existing barriers to care.

3: NeuroVoices: Ilya Kister, MD, on Understanding Long-Term Responses to Vaccines in MS

The professor of neurology at the NYU Grossman School of Medicine provided his thoughts on the VIOLA study and the importance of monitoring cell response of post-vaccinated patients with MS on DMTs.

4: Peer Exchange: Motor and Non-Motor Symptoms in Parkinson’s Disease

Episode 6 of the NeurologyLive Peer Exchange series, "Managing Neuromyelitis Optica Spectrum Disorders (NMOSD)," features Stuart Isaacson, MD; Laxman Bahroo, DO; Khashayar Dashtipor, MD; Daniel E. Kremens, MD, JD; and William Ondo, MD, describing the motor and non-motor symptoms of Parkinson’s disease, linking symptoms to OFF episodes, and how to educate patients.

5: Patient Evaluation for Excessive Daytime Sleepiness

Excessive daytime sleepiness is a hallmark of a number of sleep disorders, and ensuring the proper diagnosis and management of those presenting with it is crucial to care. In this piece, Lauren Chamberlain, DO, and Andrew Spector, MD, offer their experience.

—————————————————

Introducing: Giants of Multiple Sclerosis™

Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.

Nominate Someone Today for a 2022 Giants of Multiple Sclerosis™ Award

• Nominations are open through January 31 ,2022
• The Giants of Multiple Sclerosis™ Steering Committee will vet all nominations and vote to determine the 2022 inductees
• Nominees will be selected on the merits of their lifetime work.
• One honoree in each category who makes a measurable difference in the lives of patients will be awarded.
• The 2022 Giants of Multiple Sclerosis™ inaugural class will be announced in Spring of 2022

Nominate someone here.